Outlines - VentureVibe

Consilium sees 35% revenue surge, aims for $1.4 billion by 2026

Addex Therapeutics outlines Q3 2023 results and upcoming developments By Investing.com – Canada Boosts

Shiwali Sharma8 months ago8 months ago048 mins

© Reuters. Addex Therapeutics, throughout its Q3 2023 earnings name, supplied updates on its monetary outcomes and progress in numerous drug growth applications. The corporate highlighted achievements such because the completion of recruitment for a Part 2 epilepsy research by accomplice Janssen, and progress in its collaboration with Indivior on substance use dysfunction remedies. Addex…

Oceana Group reports promising growth with CEO's modest pay

Cerence Reports Strong Q4 2023, Outlines Future Plans for AI-Driven Automotive Solutions By Investing.com – Canada Boosts

Shiwali Sharma8 months ago8 months ago0113 mins

© Reuters. Cerence (NASDAQ:) Inc. reported strong This autumn 2023 ends in its latest earnings name, with income hitting roughly $81 million, surpassing expectations primarily resulting from its sturdy core auto enterprise efficiency. The corporate outlined future plans, emphasizing its give attention to immersive cabin experiences and the incorporation of generative AI and enormous language…